Electrochemotherapy is effective in the treatment of rat bone metastases

Clinical and Experimental Metastasis

Volumn 30, Issue 8, 2013, Pages 1033-1045

  Fini, Milena ^a   Salamanna, Francesca ^a   Parrilli, Annapaola ^a   Martini, Lucia ^a   Cadossi, Matteo ^a   Maglio, Melania ^a   Borsari, Veronica ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Bleomycin; Bone metastases; Breast cancer; Electrochemotherapy; Rat

Indexed keywords

BLEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METASTASIS; CELL DEATH; CONTROLLED STUDY; CORTICAL BONE; ELECTROCHEMOTHERAPY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; RAT; THICKNESS; TIBIA; TRABECULAR BONE;

ANIMALS; BLEOMYCIN; BONE DENSITY; BONE NEOPLASMS; BREAST NEOPLASMS; CELL SURVIVAL; COMBINED MODALITY THERAPY; ELECTROCHEMOTHERAPY; ELECTROPORATION; FEMALE; HUMANS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 84890440890     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9601-x     Document Type: Article

References (58)

1. Escoffre JM, Dean DS, Hubert M, Rols MP, Favard C (2007) Membrane perturbation by an external electric field: a mechanism to permit molecular uptake. Eur Biophys J 36:973-983. doi: 10.1007/s00249-007-0194-7
2. Gissel H, Lee RC, Gehl J (2011) Electroporation and cellular physiology. In: Kee ST, Gehl J, Lee EW (eds) Clinical Aspects of Electroporation. Springer, New York, pp 9-17
3. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37(24):4727-4733
4. Pron G, Mahrour N, Orlowski S, Tounekti O, Poddevin B, Belehradek J Jr, Mir LM (1999) Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol 57(1):45-56. doi: 10.1016/S0006-2952(98)00282-2
5. Escoffre JM, Rols MP (2012) Electrochemotherapy: progress and prospects. Curr Pharm Des 18(23):3406-3415. doi: 10.2174/138161212801227087
6. Silve A, Mir LM (2011) Cell electropermeabilization and cellular uptake of small molecules: the electrochemotherapy concept. In: Kee ST, Gehl J, Lee EW (eds) Clinical aspects of electroporation. Springer, New York, pp 69-82
7. Spugnini EP, Dotsinsky I, Mudrov N, Citro G, D'Avino A, Baldi A (2008) Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumour model of chemoresistance: sticker sarcoma. J Exp Clin Cancer Res 27:58. doi: 10.1186/1756-9966-27-58
8. Spugnini EP, Citro G, Dotsinsky I, Mudrov N, Mellone P, Baldi A (2008) Ganglioneuroblastoma in a cat: a rare neoplasm treated with electrochemotherapy. Vet J 178:291-293. doi: 10.1016/j.tvjl.2007.08.014
9. Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J (2008) Electrochemotherapy in veterinary oncology. J Vet Intern Med 22:826-831. doi: 10.1111/j.1939-1676.2008.0117.x
10. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27(1):68-72. doi: 10.1016/0277-5379(91)90064-K
11. Sersa G, Cemazar M, Miklavcic D, Chaplin DJ (1999) Tumour blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 19:4017-4022
12. Jaroszeski MJ, Coppola D, Pottinger C, Benson K, Gilbert RA, Heller R (2001) Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer 37(3):422-430. doi: 10.1016/S0959-8049(00) 00412-3
13. Engstrom PE, Ivarsson K, Tranberg KG, Stenram U, Salford LG, Persson BR (2001) Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver. Anticancer Res 21:1817-1822
14. Mitsui K, Kato K, Nakamura K, Yamada Y, Honda N, Fukatsu H, Yoshikawa K (2002) Effective treatment of bladder tumour-bearing mice by direct delivery of bleomycin using electrochemotherapy. Drug Deliv 9:249-252. doi: 10.1080/10717540260397864
15. Miyazaki S, Gunji Y, Matsubara H, Shimada H, Uesato M, Suzuki T, Kouzu T, Ochiai T (2003) Possible involvement of antitumour immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin. Surg Today 33:39-44. doi: 10.1007/s005950300006
16. Zheng MH, Feng B, Li JW, Lu AG, Wang ML, Hu WG, Ma JJ, Yu BM (2005) Effects and possible anti-tumour immunity of electrochemotherapy with bleomycin on human colon cancer xenografts in nude mice. World J Gastroenterol 11:2426-2430
17. Kitamura A (2003) Bleomycin-mediated electrochemotherapy in mouse NR-S1 carcinoma. Cancer Chemother Pharmacol 51:359-362
18. Ivanov MA, Lamrihi B, Szyf M, Scherman D, Bigey P (2003) Enhanced antitumour activity of a combination of MBD2-antisense electrotransfer gene therapy and bleomycin electrochemotherapy. J Gene Med 5:893-899
19. Soden DM, Larkin JO, Collins CG, Tangney M, Aarons S, Piggott J, Morrissey A, Dunne C, O'Sullivan GC (2006) Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett 232(2):300-310. doi: 10.1016/j.canlet.2005.03.057
20. Torrero MN, Henk WG, Li S (2006) Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res 12:257-263. doi: 10.1158/1078-0432.CCR-05-1514
21. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, Gehl J (2011) Preclinical validation of electrochemotherapy as an effective treatment for brain tumours. Cancer Res 71:3753-3762. doi: 10.1158/0008-5472. CAN-11-0451
22. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billarda V, Geertsenc PF, Larkind JO, Miklavcice D, Pavlovice I, Paulin-Kosirb SM, Cemazarb M, Morslia N, Sodend DM, Rudolfb Z, Roberta C, O'Sullivand GC, Mir LM (2006) Electrochemotherapy: an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 4:3-13. doi: 10.1016/j.ejcsup.2006.08.002
23. Giardino R, Fini M, Bonazzi V, Cadossi R, Nicolini A, Carpi A (2006) Electrochemotherapy a novel approach to the treatment of metastatic nodules on the skin and subcutaneous tissues. Biomed Pharmacother 60:458-462. doi: 10.1016/j.biopha.2006.07.016
24. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM (1993) Electrochemotherapy, a new antitumour treatment. First clinical phase I-II trial. Cancer 72:3694-3700. doi: 10.1002/1097-0142(19931215)72:12<3694: AID-CNCR2820721222>3.0.CO;2-2
25. Gehl J, Geertsen PF (2000) Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 10:585-589. doi: 10.1097/00008390-200012000-00011
26. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, Belehradek M, Gilbert R, Rols MP, Belehradek J Jr, Bachaud JM, DeConti R, Stabuc B, Cemazar M, Coninx P, Heller R (1998) Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77:2336-2342. doi: 10.1038/bjc.1998.388
27. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, Glass LF (1998) Treatment of cutaneous and subcutaneous tumours with electrochemotherapy using intralesional bleomycin. Cancer 83:148-157. doi: 10.1002/(SICI)1097-0142(19980701)83:1<148:AID-CNCR20>3.0.CO;2-W
28. Byrne CM, Thompson JF, Johnston H, Hersey P, Quinn MJ, Michael Hughes T, McCarthy WH (2005) Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res 15:45-51. doi: 10.1097/00008390-200502000-00008
29. Shimizu T, Nikaido T, Gomyo H, Yoshimura Y, Horiuchi A, Isobe K, Ebara S, Takaoka K (2003) Electrochemotherapy for digital chondrosarcoma. J Orthop Sci 8:248-251
30. Glass LF, Jaroszeski M, Gilbert R, Reintgen DS, Heller R (1997) Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 37:596-599. doi: 10.1016/S0190-9622(97)70178- 6
31. Testori A, Rossi CR, Tosti G (2012) Utility of electrochemotherapy in melanoma treatment. Curr Opin Oncol 24:155-161. doi: 10.1097/CCO. 0b013e32834fcaa8
32. Richetta AG, Curatolo P, D'Epiro S, Mancini M, Mattozzi C, Giancristoforo S, Rotunno R, Calvieri S (2011) Efficacy of electrochemotherapy in ulcerated basal cell carcinoma. Clin Ter 162:443-445
33. Marenco F, Nardò T, Savoia P, Bernengo MG (2011) Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. Eur J Dermatol 21:618-619
34. Kis E, Oláh J, Ócsai H, Baltas E, Gyulai R, Kemény L, Horvath AR (2011) Electrochemotherapy of cutaneous metastases of melanoma: a case series study and systematic review of the evidence. Dermatol Surg 37:816-824. doi: 10.1111/j.1524-4725.2011.01951.x
35. Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A, Ferrucci PF (2010) Electrochemotherapy for cutaneous and subcutaneous tumour lesions: a novel therapeutic approach. Dermatol Ther 23:651-661. doi: 10.1111/j.1529-8019.2010.01370.x
36. Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11(6):411-425. doi: 10.1038/nrc3055
37. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8):584-593. doi: 10.1038/nrc867
38. Desantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61:409-418. doi: 10.3322/caac.20134
39. Fini M, Tschon M, Ronchetti M, Cavani F, Bianchi G, Mercuri M, Alberghini M, Cadossi R (2010) Ablation of bone cells by electroporation. J Bone Joint Surg Br 92:1614-1620. doi: 10.1302/0301-620X.92B11.24664
40. Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, Clohisy DR, Mantyh PW (2000) Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Nat Neurosci 98:585-595. doi: 10.1016/S0306-4522(00) 00110-X
41. Otsu N (1979) Threshold selection method from grey level histograms. IEEE Trans Syst Man Cybern SMC 9:62-66
42. Parfitt AM (1988) Bone histomorphometry: standardization of nomenclature, symbols and units. Summary of proposed system. Bone Miner 4:1-5. doi: 10.1016/8756-3282(88)90029-4
43. Hahn M, Vogel M, Pompesius-KempaM Delling G (1992) Trabecular bone pattern factor: a new parameter for simple quantification of bone microarchitecture. Bone 13:327-330. doi: 10.1016/8756-3282(92)90078-B
44. Hildebrand T, Ruegsegger P (1997) A new method for the model independent assessment of thickness in three dimensionel images. J Microsc 185:67-75
45. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R (2000) Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 11:201-208. doi: 10.1097/00001813-200003000-00008
46. Gehl J, Skovsgaard T, Mir LM (1998) Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 9:319-325. doi: 10.1097/00001813-199804000-00005
47. Horikoshi T, Naganuma H, Ohashi Y, Ueno T, Nukui H (2000) Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells. Brain Res Bull 51:371-378. doi: 10.1016/S0361-9230(99) 00247-6
48. Byrnes RW, Petering DH (1991) Inhibition of bleomycin-induced cellular DNA strand scission by 1,10-phenanthroline. Biochem Pharmacol 41:1241-1248. doi: 10.1016/0006-2952(91)90664-Q
49. Ehrenfeld GM, Rodriguez LO, Hecht SM, Chang C, Basus VJ, Oppenheimer NJ (1985) Copper(I)-bleomycin: structurally unique complex that mediates oxidative DNA strand scission. Biochemistry 24(1):81-92. doi: 10.1021/bi00322a013
50. Kénani A, Bailly C, Houssin R, Hénichart JP (1994) Comparative subcellular distribution of the copper complexes of bleomycin-A2 and deglycobleomycin-A2. Anticancer Drugs 5:199-201. doi: 10.1097/00001813- 199404000-00010
51. Lazo JS, Schisselbauer JC, Meandzija B, Kennedy KA (1989) Initial single-strand DNA damage and cellular pharmacokinetics of bleomycin A2. Biochem Pharmacol 38:2207-2213. doi: 10.1016/0006-2952(89)90078-6
52. Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger M, Vaxelaire J, O'Reilly T, Wotherspoon G, Winter J, Green J, Urban (2002) A rat model of bone cancer pain. Pain 96:129-140. doi: 10.1016/S0304-3959(01)00437-7
53. Manthey CL, Johnson DL, Illig CR, Tuman RW, Zhou Z, Baker JF, Chaikin MA, Donatelli RR, Franks CF, Zeng L, Crysler C, Chen Y, Yurkow EJ, Boczon L, Meegalla SK, Wilson KJ, Wall MJ, Chen J, Ballentine SK, Ott H, Baumann C, Lawrence D, Tomczuk BE, Molloy CJ (2009) JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumours, bone metastases, and acute myeloid leukemia. Mol Cancer Ther 8(11):3151-3161. doi: 10.1158/1535-7163.MCT-09-0255
54. Ogawa K, Mukai T, Asano D, Kawashima H, Kinuya S, Shiba K, Hashimoto K, Mori H, Saji H (2007) Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model. J Nucl Med 48(1):122-127
55. Salamanna F, Martini L, Pagani S, Parrilli A, Giavaresi G, Maltarello MC, Fini M (2012) MRMT-1 rat breast carcinoma cells and models of bone metastases: in vitro systems to mimic the in vivo conditions. Acta Histochem 115(1):76-85. doi: 10.1016/j.acthis.2012.05.005
56. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74(5):2152-2158
57. Puc M, Corović S, Flisar K, Petkovsek M, Nastran J, Miklavcic D (2004) Techniques of signal generation required for electropermeabilization. Survey of electropermeabilization devices. Bioelectrochemistry 64(2):113-124
58. Miklavčič D, Serša G, Brecelj E, Gehl J, Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG, Jarm T (2012) Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 50(12):1213-1225. doi: 10.1007/s11517-012- 0991-8